Omnicell (NASDAQ: OMCL) reported Q2 EPS of $0.57, $0.29 better than the analyst estimate of $0.28. Revenue for the quarter came in at $299 million versus the consensus estimate of $284.57 million.

GUIDANCE:

Omnicell sees Q3 2023 EPS of $0.42-$0.52, versus the consensus of $0.45. Omnicell sees Q3 2023 revenue of $290-300 million, versus the consensus of $297.7 million.

Omnicell sees FY2023 EPS of $1.75-$2.00, versus the consensus of $1.68. Omnicell sees FY2023 revenue of $1.16-1.2 million, versus the consensus of $1.18 million. For the full year 2023, the Company expects bookings to trend toward the lower end of the previously disclosed guidance range of $1.000 billion and $1.100 billion.

For earnings history and earnings-related data on Omnicell (OMCL) click here.